ARKGvsBBPETF Comparison
VS
ARK Genomic Revolution ETF (ARKG) belongs to the BioTech & Genomics segment. Virtus LifeSci Biotech Products ETF (BBP) is part of the Tomorrow's Treatments segment. Both ETFs have the same top 1 sector exposures: Healthcare. ARKG is more expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.34% for BBP. ARKG is up 76.72% year-to-date (YTD) with +$90M in YTD flows. BBP performs worse with 31.49% YTD performance, and +$66M in YTD flows. Run a side-by-side ETF comparison of ARKG and BBP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
ARKG vs BBP performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/27/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | ARKG BBP | -3.25%-0.29% | +36.71%+8.18% | +76.72%+31.49% | +65.56%+41.36% | +132.21%+131.02% | -29.90%+106.65% |
| Flows | ARKG BBP | +$37M- | +$51M+$26M | +$90M+$66M | +$63M+$78M | -$431M+$83M | -$2.01B+$76M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | ARKG BBP | +49.99%+28.47% | +44.59%+26.49% | +44.73%+24.96% | +46.89%+26.88% |
| Max drawdown | ARKG BBP | -17.81%-8.70% | -27.52%-9.59% | -46.41%-25.54% | -76.56%-37.61% |
| Max drawdown duration | ARKG BBP | 22d69d | 126d48d | 882d292d | 1818d586d |
Trading data
ARKG | BBP | |
Last sale 10/28/2026 at 1:30 PM | $54.82 | $106.22 |
| Previous close 10/27/2026 | $51.65 | $104.89 |
| Consolidated volume 10/27/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
ARKG
is actively managed and doesn’t replicate an indexARKG | BBP | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/28/2026 at 1:30 PM
Live
Closed
ARKG | BBP | |
|---|---|---|
| Last price | $54.82 | $106.22 |
| 1D performance | +6.14% | +1.27% |
| AuM | $2.18 B | $131.09 M |
| E/R | 0.75% | 0.34% |
Characteristics
ARKG | BBP | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Ark Investment | VIRTUS Investment Partners |
| Benchmark | - | LifeSci Biotechnology Products Index |
| N° of holdings | 31 | 66 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 2, 2019 | December 16, 2014 |
| ESG | No | No |
Advertisement
Exposure
Countries
ARKG
USA
88.62%
Other
11.38%
BBP
USA
85.98%
Other
14.02%
Sectors
ARKG
Healthcare
97.89%
Other
2.11%
BBP
Healthcare
98.44%
Other
1.56%
Advertisement
Diversification
ARKG
Total weight of top 15 holdings out of 15
74.64%
BBP
Total weight of top 15 holdings out of 15
31.08%
Top 15 holdings
Data as of August 31, 2026
ARKG
10X Genomics, Inc.
9.58%
Twist Bioscience Corp.
9.13%
Tempus AI, Inc.
7.91%
CRISPR Therapeutics AG
6.10%
Personalis, Inc.
5.93%
Absci Corp.
4.88%
Natera, Inc.
4.06%
Illumina, Inc.
4.04%
Eli Lilly & Co.
3.86%
CareDx, Inc.
3.85%
Guardant Health, Inc.
3.81%
Beam Therapeutics, Inc.
3.56%
Compass Pathways Plc
3.17%
Recursion Pharmaceuticals, Inc.
2.44%
Adaptive Biotechnologies Corp.
2.32%
BBP
Moderna, Inc.
3.58%
Crinetics Pharmaceuticals, Inc.
2.94%
Omeros Corp.
2.49%
Iovance Biotherapeutics, Inc.
2.36%
Verastem, Inc.
2.15%
Precigen, Inc.
1.99%
Halozyme Therapeutics, Inc.
1.84%
Zai Lab Ltd.
1.82%
Kiniksa Pharmaceuticals International Plc
1.81%
Kura Oncology, Inc.
1.72%
BeOne Medicines Ltd.
1.70%
Rigel Pharmaceuticals, Inc.
1.69%
Nuvation Bio, Inc.
1.69%
ACADIA Pharmaceuticals, Inc.
1.67%
Protagonist Therapeutics, Inc.
1.65%
Frequently asked questions about ARKG and BBP
How have the ARKG and BBP ETFs performed in 2026?
As of October 27, 2026, ARKG is up 76.72% year-to-date (YTD), while BBP has returned 31.49%. That puts ARKG better performer ahead so far this year.
Which ETF is attracting more investor money: ARKG or BBP?
Year-to-date, the ARKG ETF saw +$90M in flows, compared to +$66M for BBP.
Which ETF is more volatile: ARKG or BBP?
Over the past year, ARKG had a volatility of 44.59%, while BBP experienced 26.49%.
Which ETF is bigger: ARKG or BBP?
As of October 27, 2026, ARKG holds $2.18 B in assets under management (AUM), while BBP manages $131.09 M.
What sectors do the ARKG and BBP ETFs invest in?
ARKG leans toward sectors like Healthcare. Meanwhile, BBP focuses on Healthcare.
What are the top holdings of the ARKG ETF and BBP ETF?
ARKG top holdings include 10X Genomics, Inc., Twist Bioscience Corp. and Tempus AI, Inc.. BBP holds in its top three: Moderna, Inc., Crinetics Pharmaceuticals, Inc. and Omeros Corp..
Which ETF is more diversified: ARKG or BBP?
ARKG holds 31 securities with 74.64% of its assets in the top 15. BBP has 66 securities and a top 15 weight of 31.08%.
Advertisement
Latest news about ARKG & BBP
The Weekly ETF Market Monitor (October 19-23, 2026)
October 26, 2026
ARKG
Biotech ETFs – Investing in Health Innovation
July 21, 2022
ARKG
Advertisement
Advertisement
